Indraprastha Medical Corporation Limited
A 6-pillar fundamental profile. Each pillar scored 0–10.
Pulse
9.0 · PositiveAnalyst revision trend (fallback)
Pulse tracks recent momentum in price, analyst revisions, and news sentiment. Higher means more positive near-term tailwinds.
Quality
8.6 · StrongPiotroski 7/9, ROCE 32.6%
Quality captures profitability, return on capital, and earnings consistency. Higher means a better business.
Moat
8.0 · StrongWide moat
Moat estimates durable competitive advantages — brand, scale, switching costs. Higher means more defensible.
Safety
8.9 · StrongD/E 0.05, Int cov 72.4x
Safety looks at balance-sheet quality, leverage, and cash generation. Higher means lower financial risk.
Growth
8.7 · StrongRev CAGR 11.7%, EPS CAGR 278.2%
Growth reflects revenue and earnings expansion over recent years. Higher means faster compounding.
Value
— · Insufficient peer dataOnly 0 MoS peers in cohort
Value measures how the stock's price compares to its intrinsic worth. Higher means more discount to fair value.
Compare with another stock
Overlay INDRAMEDCO's prism against a peer.
Share this prism
Get the full analysis
Interactive DCF, sensitivity, peer comparison, and AI summary for INDRAMEDCO.
Full analysis →Model estimate. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.